News Upcoming Events New Job Opportunity – Business Support and Marketing Officer (Permanent) Press Releases 29th April 2020 – Upperton Invest £500K in their Tablet Formulation and Manufacturing Capabilities 10th December 2019 – Upperton is Launching an Enabling Technology Screening Protocol – UpperSolv™ 29th October 2019 – Upperton continues to invest in key equipment to support expansion of its solid dosage form capabilities and CDMO Services 17th September 2019 – Upperton Pharma Solutions Investment Increases Tabletting Capabilities 8th January 2019 – MHRA Inspection success for Nottingham’s Upperton Pharma Solutions Published Papers New GMP Manufacturing Processes to Obtain Thermostable HIV-1 gp41 Virosomes Under Solid Forms for Various Mucosal Vaccination Routes Upperton Articles 29th April 2021 – Formulation Options in Nasal Drug Delivery 25th March 2021 – Formulation Options in Nasal Drug Delivery 11th March 2021 – Nasal Delivery of Therapeutics and Vaccines 15th December 2020 – Season’s Greetings 1st December 2020 – Manufacturing Clinical Supplies: The Early Phase Clinical Manufacture Timeline 10th November 2020 – Manufacturing Clinical Supplies: Planning a First-in-Human Study 27th October 2020 – Manufacturing Clinical Supplies: The Role of Placebos and the Challenges of Manufacturing they Present 24th September 2020 – Key Considerations when Choosing a Device for Dry Powder Nasal Delivery 21st July 2020 – Considerations when Developing Dry Powder Formulations for Nasal Locally Delivered Drugs 9th June 2020 – Nasal Delivery: An Alternative Route 12th May 2020 – A Tablet Development Journey at Upperton 7th April 2020 – Stages of Tablet Development: Compression Equipment Used 1 2 3 › Can we help you? Contact Us
